Companies / Day One Biopharmaceuticals, Inc. / Activity
Activity — Day One Biopharmaceuticals, Inc.
11 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Feb 17, 2026 | Bender Jeremy CEO | Sell | Common Stock | $179.3K | -15K -7.02% | 204,603 0.20% of shares | medium |
| Feb 15, 2026 | Bender Jeremy CEO | Exercise | Restricted Stock Unit (RSU) | — | -15K -6.25% | 222,188 0.22% of shares | low |
| Feb 15, 2026 | Bender Jeremy CEO | Exercise | Restricted Stock Unit (RSU) | — | -12K -8.33% | 128,565 0.12% of shares | low |
| Feb 15, 2026 | Bender Jeremy CEO | Exercise | Restricted Stock Unit (RSU) | — | -12K -12.50% | 81,816 0.08% of shares | low |
| Feb 15, 2026 | Bender Jeremy CEO | Exercise | Restricted Stock Unit (RSU) | — | -5K -25.00% | 14,250 0.01% of shares | low |
| Feb 15, 2026 | Bender Jeremy CEO | Exercise | Common Stock | — | +15K +7.22% | 220,102 0.21% of shares | low |
| Feb 15, 2026 | Bender Jeremy CEO | Exercise | Common Stock | — | +12K +6.04% | 205,290 0.20% of shares | low |
| Feb 15, 2026 | Bender Jeremy CEO | Exercise | Common Stock | — | +12K +6.42% | 193,603 0.19% of shares | low |
| Feb 15, 2026 | Bender Jeremy CEO | Exercise | Common Stock | — | +5K +2.68% | 181,915 0.18% of shares | low |
| Jan 30, 2026 | Bender Jeremy CEO | Grant | Restricted Stock Units | — | +237K | 237,000 0.23% of shares | low |
| Jan 30, 2026 | Bender Jeremy CEO | Grant | Stock Option (right to buy Common Stock) | — | +355K | 355,000 0.34% of shares | low |